"And, Impression expects to have the license and additional security protocols in place at it's Melbourne based laboratory and manufacturing facility by the first quarter of 2019."
imo if all above goes to plan this could rerate the mc at $15-20m. i.e 4-5c easily by march at latest. and that could be the start. would love to see another distribution deal while waiting. gltah and good luck to the new Innovation.
- Forums
- ASX - By Stock
- IHL
- Ann: Medicinal Cannabis Product Licensing Applications
Ann: Medicinal Cannabis Product Licensing Applications, page-40
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)